INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
Total Revenue |
0.00 |
2.85 |
2.47 |
3.97 |
3.62 |
Cost of Revenue |
- |
2.47 |
2.29 |
2.21 |
2.49 |
Gross
Profit |
0.00 |
0.39 |
0.17 |
1.77 |
1.12 |
Selling, Administration, Marketing |
- |
0.60 |
0.67 |
0.49 |
0.49 |
Deconsolidation, Gain (Loss), Amount |
- |
-0.10 |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
- |
0.23 |
0.20 |
0.66 |
0.24 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
- |
0.10 |
0.00 |
0.00 |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
- |
3.29 |
3.17 |
3.36 |
3.23 |
Operating income/-loss
|
- |
-0.44 |
-0.70 |
0.61 |
0.39 |
Other Deductions / - Income |
Interest expense |
- |
0.00 |
0.00 |
0.00 |
0.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
0.00 |
0.00 |
0.00 |
0.00 |
Investment Income, Interest |
-0.02 |
-0.02 |
-0.02 |
0.08 |
-0.01 |
Foreign Currency Transaction Gain (Loss), before Tax |
- |
0.00 |
0.00 |
0.00 |
-0.01 |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
- |
-0.02 |
-0.96 |
0.08 |
0.00 |
Government Subsidized Income |
- |
- |
- |
-0.01 |
- |
Total costs & expenses |
0.04 |
3.26 |
2.19 |
3.50 |
3.21 |
Income /-loss before income taxes |
-0.04 |
-0.41 |
0.27 |
0.48 |
0.40 |
Income taxes expenses/-benefit |
0.00 |
0.03 |
- |
0.20 |
-0.58 |
Income after income taxes |
-0.04 |
-0.44 |
0.27 |
0.28 |
0.98 |
Net income/-loss
of other equity |
0.01 |
- |
- |
- |
- |
Income Loss From Continuing Operations After Income Taxes And Before Minority Interest And Equity Method Investments |
- |
- |
- |
- |
- |
Income Loss From Discontinuing Operations Before Equity Method Investments Noncontrolling Interest |
- |
- |
- |
- |
- |
Income Loss Of Discontinued Operation Equity Method Investment Retained After Disposal |
- |
- |
- |
- |
- |
Income Loss From Discontinuing Operations After Equity Method Investments And Before Noncontrolling Interest |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-0.04 |
-0.44 |
0.27 |
0.28 |
0.98 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-0.02 |
- |
- |
- |
- |
Income Loss Of Discontinued Operation Equity Method Investment Retained After Disposal |
- |
- |
- |
0.02 |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-0.06 |
-0.44 |
0.27 |
0.28 |
0.98 |
Noncontrolling interests |
-0.04 |
-0.10 |
-0.14 |
-0.17 |
0.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.04 |
-0.34 |
0.41 |
0.45 |
0.98 |
EBIT |
-0.04 |
-0.41 |
0.27 |
0.47 |
0.40 |
EBITD |
-0.04 |
-0.39 |
0.28 |
0.49 |
0.42 |
EBITDA |
-0.04 |
-0.37 |
0.30 |
0.50 |
0.43 |